会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明授权
    • Cephalosporin derivatives
    • 头孢菌素衍生物
    • US5461044A
    • 1995-10-24
    • US369274
    • 1995-01-05
    • Masaki TsushimaKatsuyoshi IwamatsuAtsushi TamuraSeiji Shibahara
    • Masaki TsushimaKatsuyoshi IwamatsuAtsushi TamuraSeiji Shibahara
    • A61K31/545A61K31/546A61P31/04C07D501/00C07D501/59
    • C07D501/00Y02P20/55
    • As new antibacterial agent are provided cephalosporin derivatives having a general formula (I): ##STR1## wherein R.sup.1 is a hydrogen atom, a lower alkyl group or a substituted lower alkyl group, R.sup.2 is a hydrogen atom or an ester-forming group easily cleavable by an esterase present in the digestive tracts, R.sup.3 and R.sup.4 may be the same and each is independently a hydrogen atom, a halogen atom, a lower alkyl group, a lower alkenyl group, hydroxyl group, amino group or a lower alkoxy group, and a pharmaceutically acceptable salt thereof.The cephalosporin derivative of formula (I) is useful as an orally or injectably administrable cephalosporin derivative which exhibits in combination a high antibacterial activity and a favorable characteristic capable of giving a high concentration of this compound in blood when administered.
    • 作为新的抗菌剂,提供具有通式(I)的头孢菌素衍生物:其中R 1为氢原子,低级烷基或取代的低级烷基,R 2为氢原子或酯形成 可以通过存在于消化道中的酯酶容易地切割,R3和R4可以相同,各自独立地为氢原子,卤素原子,低级烷基,低级烯基,羟基,氨基或低级烷氧基 基团及其药学上可接受的盐。 式(I)的头孢菌素衍生物可用作口服或可注射给药的头孢菌素衍生物,其组合具有高的抗菌活性和在给药时能够在血液中给予高浓度该化合物的有利特征。